Cochlear Limited (FRA:OC5)
Germany · Delayed Price · Currency is EUR 119.00
-0.64 (-0.53%)
At close: Feb 20, 2026
Cochlear Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue | 2,339 | 2,343 | 2,236 | 1,936 | 1,648 | 1,498 |
Revenue Growth (YoY) | 1.28% | 4.81% | 15.47% | 17.46% | 10.06% | 13.40% |
Cost of Revenue | 636.9 | 615.2 | 562.1 | 488 | 411 | 410.2 |
Gross Profit | 1,702 | 1,728 | 1,674 | 1,448 | 1,237 | 1,087 |
Selling, General & Admin | 919.3 | 939.9 | 897.6 | 810.4 | 657.7 | 560.2 |
Research & Development | 304 | 291.5 | 277 | 244.9 | 210.7 | 195 |
Other Operating Expenses | -25.1 | -26.4 | -10.7 | -13.5 | -12 | -8.3 |
Operating Expenses | 1,198 | 1,205 | 1,164 | 1,042 | 856.4 | 746.9 |
Operating Income | 503.4 | 522.9 | 509.6 | 406.3 | 380.9 | 340.5 |
Interest Expense | -11.6 | -11 | -9.2 | -9.4 | -8.6 | -12 |
Interest & Investment Income | 12.7 | 11.7 | 19 | 16.5 | 2.4 | 3.6 |
Earnings From Equity Investments | -0.9 | -0.9 | -0.6 | -0.2 | - | -1.7 |
Currency Exchange Gain (Loss) | -2.3 | -1.6 | -4.8 | -10.2 | 0.1 | -15.8 |
EBT Excluding Unusual Items | 501.3 | 521.1 | 514 | 403 | 374.8 | 314.6 |
Merger & Restructuring Charges | - | - | -28.2 | - | - | - |
Gain (Loss) on Sale of Investments | -12.2 | -2.6 | -1.3 | -6.4 | 17.3 | 52 |
Legal Settlements | - | - | - | - | - | -6.4 |
Other Unusual Items | -33.8 | - | 0.3 | - | 1.7 | 1.6 |
Pretax Income | 455.3 | 518.5 | 484.8 | 396.6 | 393.8 | 361.8 |
Income Tax Expense | 110 | 129.6 | 128 | 96 | 104.7 | 38 |
Net Income | 345.3 | 388.9 | 356.8 | 300.6 | 289.1 | 323.8 |
Net Income to Common | 345.3 | 388.9 | 356.8 | 300.6 | 289.1 | 323.8 |
Net Income Growth | -6.80% | 9.00% | 18.70% | 3.98% | -10.72% | - |
Shares Outstanding (Basic) | 65 | 65 | 66 | 66 | 66 | 66 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 | 66 |
Shares Change (YoY) | -0.17% | -0.17% | -0.27% | 0.19% | 0.06% | 10.23% |
EPS (Basic) | 5.28 | 5.94 | 5.44 | 4.57 | 4.40 | 4.93 |
EPS (Diluted) | 5.27 | 5.93 | 5.43 | 4.56 | 4.40 | 4.93 |
EPS Growth | -6.62% | 9.17% | 19.05% | 3.76% | -10.77% | - |
Free Cash Flow | 201.2 | 175.2 | 326.4 | 312.4 | 332 | 224.2 |
Free Cash Flow Per Share | 3.07 | 2.67 | 4.97 | 4.74 | 5.05 | 3.41 |
Dividend Per Share | 4.300 | 4.300 | 4.100 | 3.300 | 3.000 | 2.550 |
Dividend Growth | 1.18% | 4.88% | 24.24% | 10.00% | 17.65% | 59.38% |
Gross Margin | 72.77% | 73.74% | 74.86% | 74.80% | 75.06% | 72.61% |
Operating Margin | 21.53% | 22.32% | 22.80% | 20.98% | 23.11% | 22.74% |
Profit Margin | 14.77% | 16.60% | 15.96% | 15.53% | 17.54% | 21.62% |
Free Cash Flow Margin | 8.60% | 7.48% | 14.60% | 16.14% | 20.14% | 14.97% |
EBITDA | 562 | 573.7 | 554.4 | 447.9 | 417.5 | 409.3 |
EBITDA Margin | 24.03% | 24.48% | 24.80% | 23.13% | 25.33% | 27.33% |
D&A For EBITDA | 58.6 | 50.8 | 44.8 | 41.6 | 36.6 | 68.8 |
EBIT | 503.4 | 522.9 | 509.6 | 406.3 | 380.9 | 340.5 |
EBIT Margin | 21.53% | 22.32% | 22.80% | 20.98% | 23.11% | 22.74% |
Effective Tax Rate | 24.16% | 25.00% | 26.40% | 24.21% | 26.59% | 10.50% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.